Multi epitope vaccine candidate design against Streptococcus pneumonia
Authors:
- 13 January 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 41 (22) , 12654-12667
Abstract
Streptococcus pneumonia, the causative agent of sepsis, meningitis and pneumonia, is held responsible for causing invasive diseases predominantly in children along with adults from both developing and developed countries. The available vaccines coverage in the context of different serotypes is limited and emergence of non-vaccine serotypes could further emerge as a threat in future. Advanced immunoinformatics tools have been used for developing a multi epitope subunit vaccine. In the current study we have subjected these four surface antigenic proteins Ply, PsaA, PspA and PspK to construct vaccine designs. We have predicted different B-cell and T-cell epitopes by using NetCTL 1.2, IEDB (Immune Epitope Databases) and ABCpred. An adjuvant (griselimycin) has been added to the vaccine construct sequence in order to improve its immunogenicity. The vaccine construct has been evaluated for its antigenicity, allergenicity, toxicity and different physio-chemical properties. The bioinformatic tools have been used for prediction, refinement and validation of the 3 D structure. Further, the vaccine structure has been docked with a toll-like receptor (TLR-4) by ClusPro 2.0. In conclusion, the proposed multi-epitope vaccine designs could potentially activate both humoral and cellular immune responses and has a potential to be a vaccine candidate against S.pneumoniae, and requires experimental validation for ensuring immunogenicity and safety profile. Communicated by Ramaswamy H. SarmaKeywords
Funding Information
- Department of Biotechnology, Government of India for RLS fellowship
This publication has 71 references indexed in Scilit:
- Designing of interferon-gamma inducing MHC class-II bindersBiology Direct, 2013
- GalaxyRefine: protein structure refinement driven by side-chain repackingNucleic Acids Research, 2013
- Mechanisms of Action of AdjuvantsFrontiers in Immunology, 2013
- Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspectiveBMC Infectious Diseases, 2012
- Next generation pneumococcal vaccinesCurrent Opinion in Immunology, 2011
- ElliPro: a new structure-based tool for the prediction of antibody epitopesBMC Bioinformatics, 2008
- Immune epitope database analysis resource (IEDB-AR)Nucleic Acids Research, 2008
- Large-scale validation of methods for cytotoxic T-lymphocyte epitope predictionBMC Bioinformatics, 2007
- ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteinsNucleic Acids Research, 2007
- Streptococcus pneumoniae colonisation: the key to pneumococcal diseaseThe Lancet Infectious Diseases, 2004